Description
Posaconazole is marketed under the brand name ZYPOSA among others. Posaconazole is a broad-spectrum, triazole antifungal medication used to treat or prevent serious fungal infections. It is used to treat invasive Aspergillus and Candida infections. It is also used for the treatment of oropharyngeal candidiasis (OPC), including OPC refractory to other drugs such as itraconazole and fluconazole.
It was approved for medical use in the European Union in October 2005, and in the United States in September 2006. It is available as a generic medication
Will this product be accessible across all regions of India?
The product – ZYPOSA (POSACONAZOLE) Tablet will be available across India on request. It is available in all the major cities in India – Delhi, Gurgain, Noida, Chandigarh, Srinagar, Jammu, Hyderabad, Chennai, Bangalore, Ahmedabad, Surat, Mumbai, Pune, Kolkata, Jaipur, Jodhpur, Hyderabad, Lucknow, Patna.
How can Aark Pharmceuticals help?
To learn about the cost price to order POSACONAZOLE online, please contact:
📞 Ms. Himanshi: 9999156233
📧 Email: sales@aarkpharma.co.in, sales@aarkpharma.com
We ensure genuine quality, secure delivery, and compliance with all buyer requirements.
Aark Pharma network in India – New Delhi | Lucknow | Varanasi | Chandigarh | Kolkata | Patna | Jodhpur.
Prior to consuming any medications, including POSACONAZOLE Tablets, it is advisable to seek guidance from a medical professional regarding its therapeutic advantages, usage instructions, and potential side effects.
List of available brand-name drugs in India for Posaconazole Tablet
List of Branded Drugs for Posaconazole Tablet: Bdposa | Noxafil | Picasa | Pocaaz-O | Posahit | Posatral | Posoxil | Posaone | Poshope | Posanat
References
- “Posaconazole: FDA-Approved Drugs”. U.S. Food and Drug Administration (FDA). Archived from the original on 20 October 2020. Retrieved 15 August 2020.
- “First Generic Drug Approvals”. U.S. Food and Drug Administration. 17 October 2022. Archived from the original on 26 January 2021. Retrieved 28 November 2022.
- Merck Sharp & Dohme (UK) Limited, Electronic medicines compendium (EMC), [Revised on June 2023] [ Accessed on 20th July 2023], https://www.medicines.org.uk/emc/files/pil.5388.pdf
- Merck & Co. Inc, US FDA, [Revised on Dec 2016] [Accessed on 20th July 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022003s018s020,0205053s002s004,0205596s001s003lbl.pdf
- KD Tripathi, Antifungal drugs, Essentials of Medical Pharmacology, 7th Edition, 2013, 795.
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Antifungal agents, 12th edition, 2011, 1581.
